Find Academic Supervisors

Christoph Merten is an Associate Professor at École Polytechnique Fédérale de Lausanne (EPFL), affiliated with the School of Engineering and the Biomedical Microfluidics Laboratory (LBMM). He is also involved in teaching within the School of Life Sciences (SV) and serves on the doctoral program committee for Biotechnology and Biological Engineering. Biomedical Microfluidics Laboratory (LBMM) School of Engineering (STI) School of Life Sciences (SV) Doctoral Program Committee (Biotechnology and Biological Engineering) His research focuses on biomedical microfluidics, bioinstrumentation, and the application of microdroplet technology for single-cell analysis. Teaching activities include courses on scientific literature analysis in bioengineering, entrepreneurship in life sciences, and practical bioinstrumentation fundamentals. Scientific literature analysis in bioengineering Entrepreneurship in life sciences Basics in bioinstrumentation Christoph Merten supervises doctoral students and has guided EPFL theses in areas related to bioengineering and microfluidics.

• Bioengineering
• Biomedical Engineering
• Microfluidics
• +3 more

Kjell Jorner is an Assistant Professor of Digital Chemistry in the Institute for Chemical and Bioengineering at ETH Zurich's Department of Chemistry and Applied Biosciences. His research group focuses on integrating computational methods and machine learning to address challenges in chemical synthesis, materials design, and reaction prediction. Education: PhD from Uppsala University (Photochemistry of aromatic compounds) Postdoctoral studies at AstraZeneca UK (Reaction prediction using computational chemistry and ML) Postdoctoral studies at University of Toronto (Molecular design of catalysts and organic electronic materials) Research Interests: Professor Jorner's work bridges computational chemistry, machine learning, and experimental design. Key areas include: Development of quantum mechanics-machine learning hybrid approaches for reaction feasibility prediction Inverse molecular design of functional materials (e.g., singlet-fission systems) Computational catalyst optimization and high-throughput screening methods Digital tools for chemical education and cheminformatics Publication Trends (2023-2025): Recent articles demonstrate a strong focus on machine learning applications in chemistry, including reaction prediction algorithms, catalyst design frameworks, and automated molecular generation. A recurring theme is the development of computational tools to accelerate materials discovery and optimize chemical processes. Laboratory & Team: Leads the Digital Chemistry research group at ETH Zurich (HCI E 137) exploring computational approaches to chemical challenges.

• Digital Chemistry
• Computational Chemistry
• Machine Learning
• +5 more

Prof. Dr. Soeren Lienkamp is an Assistant Professor at the Institute of Anatomy , Faculty of Medicine , University of Zurich . His work bridges digital education and genetic research , focusing on enhancing medical teaching through innovative formats. Research Interests : Genetics, developmental biology, kidney disease modeling, CRISPR applications, digital medical education, and advanced microscopy. Methodologies : Combines Xenopus tropicalis models, deep learning , and bioengineering to study genetic kidney disorders and improve diagnostic tools. Publication Trends : His recent articles highlight predictable genome editing , 3D imaging technologies , and mechanistic insights into kidney and eye development. Earlier works focus on ciliary function , Wnt signaling , and metabolic stress in renal cells.

• Molecular Biology
• Genetics
• Developmental Biology
• +5 more

Dr. Parth Chansoria is a Lecturer at the Department of Health Sciences and Technology at ETH Zürich, where he leads biofabrication research within the Tissue Engineering and Biofabrication (TEB) group. His work focuses on structured light technology for regenerative medicine applications, including in vivo bioprinting and microgravity-based tissue engineering. He holds Ambizione and Spark grants from the Swiss National Science Foundation and has pioneered innovations in light-guided biofabrication, collagen-based resins, and anisotropic tissue design. Research domains include: Filamented light biofabrication for aligned tissues Minimally invasive light-based in vivo bioprinting Musculoskeletal tissue engineering in microgravity Isotonic collagen-based photocrosslinkable resins He has secured over 6 patents and received prestigious awards including the ISBF Early Career Investigator Award (2022), Marie Curie Actions Fellowship (2021), and SME 30 Under 30 recognition (2021). His interdisciplinary research bridges bioengineering, materials science, and clinical applications. Key collaborations include projects at UNC Chapel Hill (USA) and NC State (USA), where he developed biomimetic patches for dynamic organ pathologies and ultrasound-assisted cell patterning. His lab explores novel bioinks, hybrid fabrication techniques, and translational applications in regenerative medicine.

• Biofabrication
• Tissue Engineering
• Regenerative Medicine
• +7 more

Sai Reddy is an Associate Professor of Systems and Synthetic Immunology at ETH Zurich's Department of Biosystems Science and Engineering (D-BSSE) in Basel, Switzerland, where he leads the Laboratory for Systems and Synthetic Immunology. Since September 2018, he has served as Vice Director of the Botnar Research Centre for Child Health (BRCCH), driving child health innovation through interdisciplinary research. Education: Bachelor of Science (Biomedical Engineering) from Northwestern University (2003) Master of Science (Biomedical Engineering) from Northwestern University (2004) Ph.D. (Bioengineering and Biotechnology) from École Polytechnique Fédérale de Lausanne (EPFL) (2008), supervised by Prof. Melody Swartz and Prof. Jeffrey Hubbell Post-doctoral fellowship under Prof. George Georgiou at the University of Texas, Austin (2008) His research pioneers the integration of computational modeling and cellular engineering to decode immune complexity. Systems Immunology employs quantitative measurements and machine learning to analyze adaptive immunity through antibody repertoire sequencing, while Synthetic Immunology reprograms immune cells via molecular engineering for cellular immunotherapy and directed evolution applications. Both fields converge on immunogenome manipulation to advance therapeutic design. Scientific Awards: KPMG tomorrow’s market award (2007) for nanoparticle vaccine technology As principal investigator, Prof. Reddy mentors graduate researchers in his laboratory; no specific advisees or grant awards are detailed in the text. His leadership at BRCCH amplifies translational impact on child health, though operational grant mechanisms remain undisclosed. The Laboratory for Systems and Synthetic Immunology operates from ETH Zurich's Basel campus at Klingelbergstrasse 48, Switzerland, focusing on high-throughput sequencing and synthetic biology methods to engineer immune responses.

• Systems Immunology
• Synthetic Immunology
• Antibody Repertoire Sequencing
• +5 more

Dr. Manuel Carro Dominguez is a Researcher at the Department of Neural Control of Movement, ETH Zürich. His work focuses on understanding the neural mechanisms underlying sleep dynamics, arousal regulation, and their impact on motor performance and cardiovascular function. He specializes in techniques such as auditory stimulation, pupil-based neurofeedback, and EEG/ECG monitoring to explore sleep oscillations, cortical excitability, and their clinical applications. His research bridges neuroscience, biomedical engineering, and sleep medicine, with a particular emphasis on enhancing human physiology through targeted interventions during sleep. Key research interests include: sleep modulation via auditory stimuli, pupilometry as a marker of arousal states, and the development of medical devices for gas sensing and closed-loop biofeedback systems. His studies often integrate multidisciplinary approaches to address translational challenges in neurophysiology and cardiovascular health. Recent publications highlight advancements in auditory stimulation effects on cardiac function, the role of K-complexes in sleep dynamics, and the design of gas sensing technologies for biomedical applications. His work contributes to both fundamental neuroscience and applied biomedical engineering, aiming to improve clinical outcomes through innovative sleep-based interventions.

• Neuroscience
• Sleep Research
• Neural Engineering
• +3 more

Ueli Grossniklaus is an Ordinary Professor at the University of Zurich within the Faculty of Mathematical and Natural Sciences , affiliated with the Department of Plant and Microbiology . His work focuses on plant developmental biology, particularly epigenetic and genetic mechanisms governing reproduction and adaptation. Key Courses: Epigenetics, Plant Biology Workshop, Group Seminars on Current Research Laboratory Techniques: Advanced methods in plant cell mechanics, transcriptomics, and genome editing Research Interests span plant epigenetics, reproductive biology, and the interplay between environmental stress and genetic regulation. He investigates: Mechanistic control of gametogenesis and fertilization Epigenetic contributions to plant adaptation Evolutionary implications of asexual reproduction Biophysical forces in plant cell growth Publication Trends (2025–2018) reveal expertise in: Arabidopsis and fern model systems Epigenetic regulation (DNA methylation, histone dynamics) Apomixis and hybrid seed failure mechanisms Biomechanics of pollen tubes and carnivorous plants Genome editing tools (CRISPR) and long-read sequencing Scientific Collaborations include interdisciplinary projects on: Microfluidic devices for plant cell analysis Gene drive ecology and ethics 3D imaging of plant reproductive structures Advising and Grants focus on mentoring through research internships in developmental biology, genetics, and systems biology. His lab engages in: Epigenetic response to environmental stress Cell wall mechanics in reproduction Computational modeling of plant growth Laboratory Teams integrate plant biologists, bioengineers, and computational scientists to study: Mechanistic gene regulation Evolutionary developmental biology Microrobotics for cellular force measurement

• Plant Developmental Biology
• Epigenetics
• Plant Genetics
• +5 more

Luca Varani is a Professor and Group Leader of the Structural Biology group at the Institute for Research in Biomedicine (IRB), affiliated with the Università della Svizzera italiana in Bellinzona, Switzerland. His research focuses on understanding the molecular mechanisms of antibody-pathogen interactions and engineering novel therapeutic antibodies. Education: Chemistry degree from University of Milan, PhD from MRC-Laboratory of Molecular Biology (University of Cambridge) Former postdoc at Stanford with EMBO fellowship Founder of CLBiotech (2022), a nanobody discovery and engineering startup Varani's research spans structural biology, immunology, and biophysics with emphasis on viral pathogenesis and antibody engineering. His work combines experimental and computational approaches to study antibody-antigen interactions, particularly against emerging pathogens like SARS-CoV-2, Zika, and Dengue viruses. His group has pioneered structure-guided antibody engineering techniques that have led to multiple high-impact publications in journals like Nature, Cell, and Science. Analysis of Varani's recent publications reveals a strong focus on SARS-CoV-2 antibody responses, with significant contributions to understanding neutralizing mechanisms, viral escape, and therapeutic antibody development. His work also extends to prion diseases, cancer immunology, and flaviviruses, demonstrating a multidisciplinary approach that bridges structural biology with translational medicine. As a reviewer for high-impact journals and international granting agencies, Varani contributes significantly to the scientific community. He also serves as an evaluator for European startup accelerator programs and consults for antibody biotechnology companies, translating academic research into practical applications. Varani leads a highly multidisciplinary research team that employs techniques ranging from NMR spectroscopy and X-ray crystallography to cellular assays and computational modeling. His laboratory has been instrumental in developing bispecific antibodies against SARS-CoV-2 and other pathogens, with several candidates advancing toward clinical trials.

• Structural Biology
• Antibody Engineering
• Viral Pathogenesis
• +4 more

Dr. Ana Isabel Benítez Mateos is a Researcher affiliated with ETH Zurich's Institute for Chemical and Bioengineering (ICB), part of the Department of Chemistry and Applied Biosciences. She holds a staff position within the Professorship for Biochemical Engineering. Her work focuses on biochemical engineering and related disciplines, including bioprocess optimization, sustainable chemical processes, and industrial biocatalysis. Her professional profile emphasizes technical expertise in chemical and bioengineering systems, with potential involvement in laboratory operations, research projects, and collaborative initiatives at ETH Zurich. Contact details are available via email .

• Biochemical Engineering
• Bioprocess Engineering
• Chemical Engineering
• +3 more

Professor Sebastian Hiller is a Full Professor at the Biozentrum of the University of Basel, Switzerland, where he leads a research group focused on structural biology and biophysics. His laboratory specializes in using nuclear magnetic resonance (NMR) spectroscopy to elucidate the structures and functions of proteins and their interactions at the atomic level. His research spans several key areas including molecular chaperones and protein folding mechanisms, outer membrane protein biogenesis in bacteria, and kinase signaling pathways. Notably, his group has made significant contributions to understanding how chaperones like trigger factor function, the mechanisms of outer membrane protein assembly through the Bam complex, and dynamic kinase interactions. Their work has direct implications for neurodegenerative diseases and antibiotic development. The Hiller lab's recent publications demonstrate a strong focus on NMR methodology development, protein folding dynamics, and structural mechanisms of antibiotic action. Their research on darobactin's mechanism of action against Gram-negative bacteria represents a significant advance in antibiotic discovery. The group frequently publishes in high-impact journals including Nature, Science, and Nature Communications. ICMRBS Founder's Medal (2018) EMBO Young Investigator (2014) ERC starting grant (2011) SNSF professorship (2010) SNSF scholarship for young researchers (2008) Professor Hiller supervises numerous PhD students and postdoctoral researchers, with many alumni having secured prestigious positions in academia and industry. His laboratory maintains strong collaborations across multiple institutions and has received significant funding through ERC grants and other competitive mechanisms. The Hiller group also operates advanced NMR facilities that serve the broader research community at the University of Basel.

• Structural Biology
• NMR Spectroscopy
• Protein Folding
• +4 more

Christoph Müller is a Full Professor of Energy Science and Engineering at ETH Zürich's Department of Mechanical and Process Engineering. He leads the Laboratory of Energy Science and Engineering, focusing on sustainable energy generation, heterogeneous catalysis, and granular systems. His research integrates experimental methods like Magnetic Resonance Imaging (MRI) and Discrete Element Modelling (DEM) with mathematical modeling to address industrial energy challenges. Education: Dipl.-Ing. from Technical University of Munich (2004), PhD in Chemical Engineering from the University of Cambridge (2008). Notable awards include the Danckwerts-Pergamon Prize (2009) and DAAD Scholarship (2005). He teaches courses such as Thermodynamics I and Thermo- and Fluid Dynamics. Research interests span CO₂ capture via chemical looping, catalytic hydrogenation, and granular flow dynamics. Recent work explores catalyst design for propane dehydrogenation, MXene-based ammonia synthesis, and MgO-based CO₂ sorbents. His lab employs advanced techniques like operando X-ray absorption spectroscopy to study catalyst behavior under reaction conditions. Key achievements include developing stable PtGa propane dehydrogenation catalysts and advancing understanding of Na₂CO₃-promoted CO₂ sorbents. His work on fluidized bed hydrodynamics via MRI contributes to reactor design optimization. Müller's interdisciplinary approach bridges fundamental science and industrial application, addressing global energy sustainability challenges.

• Energy Science and Engineering
• Heterogeneous Catalysis
• CO₂ Capture and Conversion
• +3 more

Martin Fussenegger is a Full Professor at the Department of Biosystems Science and Engineering (D-BSSE) of ETH Zurich in Basel and holds a joint appointment at the University of Basel . His work centers on mammalian cell engineering, synthetic gene circuits, and theranostic designer cell implants that interface with host metabolism to treat metabolic disorders. Education: Graduated with Werner Arber at the Biocenter of the University of Basel (1992) Ph.D. in Medical Microbiology (1994) at the Max Planck Institute of Biology, Tübingen Postdoctoral studies at the Max Planck Institute of Infection Biology, Berlin (1995) Research Areas: Martin Fussenegger’s research explores the design of synthetic gene circuits that enable precise control of cellular functions, the development of theranostic cell implants for metabolic disorders, and the engineering of mammalian cells to interface with host physiology. His work bridges biotechnology, bioengineering, and molecular biology. Scientific Awards: Gaden Award Merck Cell Culture Engineering Award Medal of the European Society for Animal Cell Technology (ESACT) Gutenberg Chair Excellence Award European Research Council (ERC) Advanced Grant Award (twice) James E. Bailey Award Expert Panels and Memberships: He serves as an expert for the Swiss Innovation Agency (Innosuisse), the Swiss Agency for Therapeutic Products (Swissmedic), and the Global Forum on Technology (GFTech) of the OECD. He is a member of prestigious academies including the American Institute for Medical and Biological Engineering (AIMBE), the Swiss Academy of Engineering Sciences (SATW), the German National Academy of Science and Engineering (Acatech), the European Molecular Biology Organization (EMBO), the Academia Europaea (AE), and the U.S. National Academy of Engineering (NAE).

• Biotechnology
• Bioengineering
• Synthetic Biology
• +4 more

Andrew de Mello serves as Full Professor and Deputy Head at ETH Zurich's Department of Chemistry and Applied Biosciences, where he also leads the Institute of Chemical and Bioengineering. His research group operates at the intersection of microfluidics and nanoscale science, maintaining a highly international team with members from over 15 countries. The deMello Group specializes in microfluidic device development for high-throughput biological analysis, ultrasensitive optical detection , nanofluidic chemical synthesis systems , and imaging flow cytometry . Their work spans analytical chemistry, biomedical engineering, and diagnostic applications, with recent projects focusing on paper-based electrofluidic devices, synthetic gene circuits for tuberculosis detection, and droplet-based microfluidics for mRNA screening. Professor de Mello's scholarly contributions include over 350 peer-reviewed publications and two co-authored books. His editorial leadership includes serving as Associate Editor for ACS Sensors and on editorial boards for Advanced Materials Technologies, Chem, and Chemistry World. Advances in Measurement Science Lectureship (ACS, 2020) Qinghe Lectureship (Chinese Academy of Sciences, 2018) Corday-Morgan Medal (RSC, 2009) Clifford Paterson Medal (Royal Society, 2009) SAC Silver Medal (RSC, 2002) His research group actively mentors doctoral students across diverse projects including microrobot fabrication, tumor spheroid vascularization, and spatial tissue mapping. Current grants support development of diagnostic platforms for kidney function monitoring and drug-resistant tuberculosis detection, with collaborations spanning ETH Zurich, Universitätsspital Zürich, and international institutions.

• Microfluidics
• Nanotechnology
• Bioanalytical Chemistry
• +5 more

Daniel J. Müller is a Full Professor of Biophysics at ETH Zurich's Department of Biosystems Science and Engineering since 2010. He served as Head of the Department (2021-2024) and co-directs the NCCR Molecular Systems Engineering (since 2014) and Basel Research Center for Child Health (BRCCH, since 2024). Education: Physics Diploma (Technical University of Berlin, 1993), PhD in Biophysics (University of Basel, 1997), Habilitation in Biophysics (University of Basel, 2000). Müller's research pioneers bionanotechnological tools for quantifying molecular interactions in living systems. His group develops single-molecule force spectroscopy and multiparametric nanoscopic imaging to study cellular mechanics, membrane protein dynamics, and neuronal reprogramming, revealing fundamental biological processes at molecular resolution. Key awards include the EBSA NanoTemper Award (2025), Honorary Professorship from Heidelberg University (2023), Humboldt Research Award (2022), EMBO Membership (2016), and Marsilius Medal (2019). He mentors students through courses like 'Nanomachines of the Cell' and leads major initiatives including the NCCR (30+ research groups) and BRCCH. His 2023 Roche partnership advances translational bioengineering for next-generation medical solutions. Müller directs the Biophysics research group at ETH Zurich, driving innovation in molecular systems engineering through collaborations with institutions like the Max Planck Society and University of Basel.

• Biophysics
• Bionanotechnology
• Single-Molecule Biophysics
• +4 more

Prof. Enkelejda Miho is a Professor of Digital Life Sciences at the School of Life Sciences, FHNW, leading the aiHealthLab. Her work bridges computer science/AI with life sciences, focusing on drug discovery, personalized medicine, and immunology. She holds roles as Team Leader at aiHealthLab and Group Leader at the Swiss Bioinformatics Institute. Research Interests : She applies machine learning to analyze immune repertoires, antibody engineering, and autoimmunity diagnostics. Her lab develops computational tools like the RWD-Cockpit for real-world data analysis and synthetic antibody-antigen models (Absolut!) to advance biotherapeutics. Her work on dengue immunity and monoclonal gammopathies highlights translational applications. Key Projects : The aiHealthLab focuses on AI-driven diagnostics and therapeutics. Her contributions include AI frameworks for antibody specificity prediction, age-related immune repertoire changes, and large-scale network analysis of antibody repertoires. Labs/Teams : Leads aiHealthLab and collaborates with the Swiss Bioinformatics Institute, integrating computational and experimental immunology.

• Digital Life Sciences
• Medical Informatics
• Artificial Intelligence in Healthcare
• +4 more